Will Morton[email protected]Molecular ImagingPET tracks long-term changes in patients with dementiaPET imaging can assess brain metabolism changes over time in individuals with prodromal dementia with Lewy bodies (DLB) and probable DLB.January 13, 2025InterventionalY-90 radioembolization safe in people living with HIVYttrium-90 (Y-90) radioembolization to treat liver cancer appears safe and effective in people living with HIV.January 10, 2025Molecular ImagingAnimal study shows PET/CT can detect brain damage from TMT poisoningA feasibility study in rats suggests that PET/CT can detect brain damage caused by trimethyltin chloride (TMT), a hazardous compound widely used in plastics production.January 9, 2025Molecular ImagingNew criteria released for amyloid and tau PET imagingNew appropriate use criteria for amyloid and tau PET imaging of amyloid and tau pathology has been released.January 8, 2025Molecular ImagingPET scans can decrease unnecessary lymph node proceduresNegative prostate-specific antigen PET scans can be used to avoid unnecessary pelvic lymph node dissection in certain prostate cancer patients undergoing radical prostatectomies.January 7, 2025Molecular ImagingPSMA-PET imaging spiked after FDA approvalRates of PET prostate cancer imaging increased rapidly after its approval by the U.S. Food and Drug Administration (FDA).January 6, 2025InterventionalAre patients satisfied with interventional radiology experiences?Interventional radiologists who excel in communication, positive outcomes, and cultural competence receive high patient ratings.January 2, 2025Nuclear MedicineKidneys appear to tolerate Lu-177 treatmentsKidney-absorbed doses of lutetium-177 (Lu-177)-based treatments for prostate cancer and neuroendocrine tumors appear to be below toxicity thresholds.December 19, 2024Molecular ImagingAuntMinnie.com Molecular Imaging InsiderRSNA 2024 wrapped up in Chicago recently, with theranostics taking center stage. Click "Read More" to learn about one more study from the meeting – findings that suggest African Americans respond more favorably to Ra-223 treatment – and other news.December 17, 2024Molecular ImagingAfrican American men respond more favorably to Ra-223 therapyAfrican American men with metastatic castrate-resistant prostate cancer may respond more favorably than white men to treatment with radium-223.December 17, 2024Page 1 of 43Next PageTop StoriesArtificial IntelligenceAI will transform early cancer detection, save lives in 2025In a new column, Roland Rott of GE HealthCare makes the case that 2025 will be a watershed year for AI in radiology.Molecular ImagingPET tracks long-term changes in patients with dementiaWomens ImagingCEM-, radiomics-based models predict breast biopsy outcomesWomens ImagingGenetic testing, risk assessment tied to more breast MRI uptakeMRIDeep-learning model based on MRI data predicts prostate cancer risk